SEC Form 4 · accession 0001354488-16-007699
PERNIX THERAPEUTICS HOLDINGS, INC. · PTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tasos Konidaris
Director
Period of report
May 26, 2016
Accepted (ET)
May 31, 2016 · 4:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001024126
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options (right to buy)F1 | $0.45 | May 26, 2016 | A | 40,000 | A | May 26, 2017 | May 26, 2026 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1The stock options vest in annual 10,000 share installments with the first installment vesting on the first anniversary of the date of grant and the final installment vesting on the fourth anniversary thereof.